NeuroCycle Therapeutics, Inc.
Raleigh, NC · Biotech · Acquired
Subtype-selective GABA-A receptor positive allosteric modulators for Dravet syndrome
neurocycletherapeutics.com →- Grants
- $720K
- 2 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- 17
- 4 granted · 13 pending
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓201820192020
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Subtype Selective GABAA Receptor Modulators for the Treatment of Dravet Syndrome | $494,651 | |
| Federal grant | Department of Health and Human Services · Phase I · Development of a fixed-dose combination therapy for the treatment of chronic musculoskeletal pain | $225,531 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2992 | VASADE BIOSCIENCES, INC. | — | — |
| 2993 | Pharvaris | — | — |
| 2994 | TRIMTECH | — | — |
| 2995 | NeuroCycle Therapeutics, Inc. | — | — |
| 2996 | PROVAIDYA | — | — |
| 2997 | Pathways Bioscience, LLC | — | — |
| 2998 | End2End Genomics LLC | — | — |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Patents
- Gabaa Positive Allosteric Modulator Compounds, Methods Of Making, And Uses Thereofgranted
- CRYSTALLINE SALTS OR CO-CRYSTALS OF 2',6-DIFLUORO-5'-[3-(1-HYDROXY-1-METHYLETHYL)-IMIDAZO[1,2-b][1,2,4]TRIAZIN-7-YL]BIPHENYL-2-CARBONITRILE WITH PHOSPHORIC ACID AS GABAA POSITIVE ALLOSTERIC MODULATORSapplication
- CRYSTALLINE SALTS OR CO-CRYSTALS OF 2',6-DIFLUORO-5'-[3-(1-HYDROXY-1-METHYLETHYL)-IMIDAZO[1,2-b][1,2,4]TRIAZIN-7-YL]BIPHENYL-2-CARBONITRILE WITH p-TOLUENESULOFONIC ACID AS GABAA POSITIVE ALLOSTERIC MODULATORSgranted
- Gabaa Positive Allosteric Modulator Compounds For Treatment Of Itch And/or Dermatitisgranted
- Treatment Of Epileptic Conditions With Gabaa Receptor Modulatorsapplication
- CRYSTALLINE SALTS OR CO-CRYSTALS OF 2',6-DIFLUORO-5'-[3-(1-HYDROXY-1-METHYLETHYL)-IMIDAZO[1,2-b][1,2,4]TRIAZIN-7-YL]BIPHENYL-2-CARBONITRILE WITH PHOSPHORIC ACID AS GABAA POSITIVE ALLOSTERIC MODULATORSgranted
- Gabaa Positive Allosteric Modulator Compounds, Methods Of Making, And Uses Thereofapplication
- Gabaa Positive Allosteric Modulator Compounds For Treatment Of Itch And/ Or Dermatitisapplication
- Gabaa Positive Allosteric Modulator Compounds, Methods Of Making, And Uses Thereofapplication
- Use Of Gabaa Receptor Modulators For Treatment Of Painapplication
- Gabaa Positive Allosteric Modulator Compounds For Treatment Of Itch And/or Dermatitisapplication
- Gabaa Positive Allosteric Modulator Compounds, Methods Of Making, And Uses Thereofapplication
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.